Romaguera J - Search Results

1

Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.

Zhou Y, Zhang L, Romaguera J, Delasalle K, Han X, Du X, Kwak L, Yi Q, Wang M. Zhou Y, et al. Among authors: romaguera j. Am J Hematol. 2008 Feb;83(2):144-9. doi: 10.1002/ajh.21036. Am J Hematol. 2008. PMID: 17722077 Free article. Review.

2

A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.

Wang M, Zhang L, Han X, Yang J, Qian J, Hong S, Lin P, Shi Y, Romaguera J, Kwak LW, Yi Q. Wang M, et al. Among authors: romaguera j. Clin Cancer Res. 2008 Apr 1;14(7):2154-60. doi: 10.1158/1078-0432.CCR-07-4409. Clin Cancer Res. 2008. PMID: 18381957 Free article.

3

Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.

Wang M, Fayad L, Cabanillas F, Hagemeister F, McLaughlin P, Rodriguez MA, Kwak LW, Zhou Y, Kantarjian H, Romaguera J. Wang M, et al. Among authors: romaguera j. Cancer. 2008 Nov 15;113(10):2734-41. doi: 10.1002/cncr.23880. Cancer. 2008. PMID: 18973182 Free article. Clinical Trial.

4

Multiple myeloma, painful neuropathy, acupuncture?

Zhou Y, Garcia MK, Chang DZ, Chiang J, Lu J, Yi Q, Romaguera J, Delasalle K, Guo Y, Forman A, Fang W, Wang M. Zhou Y, et al. Among authors: romaguera j. Am J Clin Oncol. 2009 Jun;32(3):319-25. doi: 10.1097/COC.0b013e318173a520. Am J Clin Oncol. 2009. PMID: 19887992 Review.

5

Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma.

Jung HJ, Chen Z, Fayad L, Wang M, Romaguera J, Kwak LW, McCarty N. Jung HJ, et al. Among authors: romaguera j. Exp Hematol. 2012 Feb;40(2):107-18.e2. doi: 10.1016/j.exphem.2011.10.004. Epub 2011 Oct 21. Exp Hematol. 2012. PMID: 22024108 Free PMC article.

6

Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacy.

Desai M, Newberry KJ, Romaguera J, Zhang L, Ou Z, Wang M. Desai M, et al. Among authors: romaguera j. J Hematol Oncol. 2013 Aug 2;6:55. doi: 10.1186/1756-8722-6-55. J Hematol Oncol. 2013. PMID: 23915913 Free PMC article. Review.

7

Current regimens and novel agents for mantle cell lymphoma.

Chen Y, Wang M, Romaguera J. Chen Y, et al. Among authors: romaguera j. Br J Haematol. 2014 Oct;167(1):3-18. doi: 10.1111/bjh.13000. Epub 2014 Jun 28. Br J Haematol. 2014. PMID: 24974852 Free article. Review.

8

Current trials for frontline therapy of mantle cell lymphoma.

Steiner RE, Romaguera J, Wang M. Steiner RE, et al. Among authors: romaguera j. J Hematol Oncol. 2018 Jan 27;11(1):13. doi: 10.1186/s13045-018-0556-x. J Hematol Oncol. 2018. PMID: 29374487 Free PMC article. Review.

9

Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.

Zhang L, Yang J, Qian J, Li H, Romaguera JE, Kwak LW, Wang M, Yi Q. Zhang L, et al. Among authors: romaguera je. Blood. 2012 Nov 1;120(18):3783-92. doi: 10.1182/blood-2012-04-424630. Epub 2012 Sep 11. Blood. 2012. PMID: 22968454 Free PMC article.

10

Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo.

Wang M, Han XH, Zhang L, Yang J, Qian JF, Shi YK, Kwak LW, Romaguera J, Yi Q. Wang M, et al. Among authors: romaguera j. Leukemia. 2008 Jan;22(1):179-85. doi: 10.1038/sj.leu.2404959. Epub 2007 Sep 27. Leukemia. 2008. PMID: 17898787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters